TNF Pharmaceuticals (TNFA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

TNFA TNF Pharmaceuticals

Watchlist

1.360
-0.110-7.48%

Close Dec 20 16:00 ET

1.380
+0.020+1.47%

Post 20:01 ET

3.75MMarket Cap-0.10P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

TNF Pharmaceuticals, Renova Health Announce Trial to Explore Isomyosamine
TipRanksDec 19 09:25 ET
Express News | Tnf Pharmaceuticals Inc - Enters Collaborative Agreement With Renova Health
ReutersDec 19 09:15 ET
Express News | Tnf: Fully Funded Study to Evaluate Wegovy and Ozempic Patients at Risk for Increased Inflammation Associated With Sarcopenic Muscle Deterioration
ReutersDec 19 09:15 ET
TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
BusinesswireDec 19 09:15 ET
Express News | Tnf Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
ReutersDec 9 09:00 ET
TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
BusinesswireDec 9 09:00 ET

Comments

Jaguar8

Dec 19 08:15

NEWS

$TNF Pharmaceuticals (TNFA.US)$
TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
Thursday, 19th December at 9:15 am
Fully funded study to evaluate Wegovy and Ozempic patients at risk for increased inflammation associated with sarcopenic muscle deterioration
Collaboration partner to use AI and machine learning to identify targeted patient pool
Potential entry into high growth GLP-1 market valued at nearly $50 bill...

Stock_Drift

Dec 9 10:18

Low Floats 12:17pm

$Streamline Health Solutions (STRM.US)$ $China SXT Pharmaceuticals (SXTC.US)$ $TNF Pharmaceuticals (TNFA.US)$ $Versus Systems (VS.US)$ $XChange TEC (XHG.US)$ $Senti Biosciences (SNTI.US)$ $Iveda Solutions (IVDA.US)$ $Cyclerion Therapeutics (CYCN.US)$ $Sonnet BioTherapeutic (SONN.US)$ $Gaxos.ai (GXAI.US)$ $Zeo Energy (ZEO.US)$ $Asset Entities (ASST.US)$
📊⚡️📊

Trytosaveabit

Dec 9 08:04

Update

$TNF Pharmaceuticals (TNFA.US)$ Reuters· 3 mins ago
Tnf Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Trytosaveabit

Oct 2 08:11

Update

$TNF Pharmaceuticals (TNFA.US)$ TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
1 MINUTE AGO, 9:10 AM EDT
VIA BUSINESSWIRE
Prevail Partners, LLC investment priced at more than a 40% premium to market
Prevail InfoWorks, Inc. to act as Clinical Research Organization partner; global full service CRO with hundreds of clinical trials over a decade
TNF Pharmaceuticals fully funded for clinical trials for next two years

Trytosaveabit

Jul 24 07:21

Hehehe! WooHooo

$TNF Pharmaceuticals (TNFA.US)$ What i say yesterday when it was still MYMD? Ticker change today!

Heat List

Overall

No Data